Atom Investors’s T2 Biosystems, Inc TTOO Stock Holding History

Atom Investors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	-$12K	–	347
2021 Q4	$12K	Buy	+5	New	+$17.4K	﹤0.01%	261

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Atom Investors's TTOO Position: Q1 2022 in Review

Atom Investors sold out of T2 Biosystems, Inc (TTOO) in Q1 2022, closing a stake of 5 shares — an estimated $12K sold.

Atom Investors first reported a position in TTOO in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 67 funds tracked by Wall St. Rank hold TTOO as of Q1 2022.

Atom Investors reported no remaining T2 Biosystems, Inc position as of Q1 2022 after selling out during the quarter.
Atom Investors sold 5 T2 Biosystems, Inc shares in Q1 2022, an estimated $12K.
Atom Investors first reported a position in T2 Biosystems, Inc in Q4 2021 and held it in 1 quarter.
Atom Investors's T2 Biosystems, Inc position peaked at $12K in Q4 2021.
67 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2022.

Based on Atom Investors's 13F filing for Q1 2022, filed 16 May 2022.